Luca Chiovato Selected Research

Thyroxine (Levothyroxine)

8/2022	A unique presentation of Graves' disease in a pregnant woman with severe hypothyroidism.
1/2019	Hypothyroidism in Context: Where We've Been and Where We're Going.
11/2016	GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASE.
4/2014	Metformin-induced thyrotropin suppression is not associated with cardiac effects.
1/2013	Improvement of intra-epidermal nerve fibre density in hypothyroidism after L-thyroxine therapy.
9/2011	Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome.
9/2009	TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients.
10/2003	Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Chiovato Research Topics

Disease

18	Thyroid Diseases (Thyroid Disease) 01/2020 - 12/2002
17	Thyroid Neoplasms (Thyroid Cancer) 05/2023 - 01/2002
14	Hypothyroidism 08/2022 - 10/2003
14	Neoplasms (Cancer) 01/2022 - 07/2002
10	COVID-19 01/2023 - 01/2020
10	Graves Disease (Basedow Disease) 01/2019 - 07/2002
9	Hyperthyroidism 08/2022 - 12/2002
8	Inflammation (Inflammations) 01/2020 - 07/2002
6	Obesity 05/2024 - 02/2004
6	Thyroid Nodule (Nodule, Thyroid) 01/2020 - 01/2002
5	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2020 - 09/2003
5	Adenoma (Adenomas) 06/2011 - 01/2002
4	Cytokine Release Syndrome 01/2021 - 01/2020
4	Multiple Sclerosis 01/2017 - 05/2011
4	Graves Ophthalmopathy 11/2016 - 05/2002
3	Thyroiditis 01/2020 - 03/2004
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 04/2007
3	Type 2 Diabetes Mellitus (MODY) 01/2015 - 09/2009
2	Morbid Obesity 05/2024 - 02/2014
2	Weight Gain 01/2023 - 11/2014
2	Body Weight (Weight, Body) 01/2023 - 11/2014
2	Disease Progression 01/2021 - 05/2019
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020 - 09/2011
2	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2019 - 09/2003
2	Dyslipidemias (Dyslipidemia) 01/2018 - 10/2014
2	Hypertension (High Blood Pressure) 01/2018 - 01/2018
2	Hepatitis 12/2017 - 04/2007
2	Relapsing-Remitting Multiple Sclerosis 01/2017 - 01/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2012 - 02/2008
1	Avitaminosis (Vitamin Deficiency) 05/2024
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 01/2020
1	Overweight 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Infertility (Sterility) 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Insulin Resistance 01/2020

Drug/Important Bio-Agent (IBA)

14	ChemokinesIBA 01/2022 - 07/2002
8	Thyrotropin Receptors (Thyrotropin Receptor)IBA 08/2022 - 06/2002
8	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2022 - 10/2003
8	AntibodiesIBA 08/2022 - 09/2003
7	InterferonsIBA 01/2020 - 01/2011
7	Thyroglobulin FDA Link 01/2020 - 05/2002
6	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2002
5	CytokinesIBA 12/2021 - 01/2013
5	Thyroid HormonesIBA 01/2020 - 11/2004
5	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 09/2009
5	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2019 - 09/2003
4	Methimazole (Thiamazole)FDA LinkGeneric 08/2022 - 09/2010
4	IodineIBA 04/2019 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2016 - 01/2013
3	Messenger RNA (mRNA)IBA 05/2023 - 07/2002
3	Chemokine ReceptorsIBA 01/2020 - 04/2016
3	LigandsIBA 01/2018 - 04/2007
3	Antithyroid Agents (Antithyroid Drugs)IBA 01/2017 - 10/2008
3	CXC ChemokinesIBA 01/2013 - 04/2007
3	IodidesIBA 07/2004 - 01/2002
3	Troleandomycin (TAO)FDA Link 09/2003 - 05/2002
2	Interleukin-8 (Interleukin 8)IBA 05/2023 - 01/2022
2	CreatinineIBA 01/2023 - 10/2021
2	SeleniumIBA 01/2020 - 04/2017
2	Iodide Peroxidase (Deiodinase)IBA 01/2018 - 09/2003
2	CholesterolIBA 01/2018 - 02/2014
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 02/2008
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 11/2016 - 02/2008
2	Estrogen ReceptorsIBA 06/2015 - 08/2012
2	Glatiramer Acetate (Copaxone)FDA Link 12/2014 - 05/2011
2	LipidsIBA 08/2014 - 02/2014
2	Estrogens (Estrogen)FDA Link 08/2012 - 06/2009
2	CXCR3 ReceptorsIBA 01/2011 - 07/2002
2	Transcription Factors (Transcription Factor)IBA 04/2006 - 08/2004
2	Blocking AntibodiesIBA 09/2004 - 03/2004
2	AutoantigensIBA 03/2004 - 12/2002
2	sodium-iodide symporter (sodium iodide symporter)IBA 10/2003 - 01/2002
1	MicronutrientsIBA 05/2024
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Fibrinogen (Factor I)FDA Link 10/2021
1	Ferritins (Ferritin)IBA 10/2021
1	C-Reactive ProteinIBA 10/2021
1	ProcalcitoninIBA 10/2021
1	fibrin fragment D (D-dimer)IBA 10/2021
1	Chemokine CXCL10IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Liraglutide FDA Link 01/2020
1	Testosterone (Sustanon)FDA Link 01/2020
1	Selenomethionine (Sethotope)FDA Link 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Chemotactic FactorsIBA 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020

Therapy/Procedure

15	Therapeutics 08/2022 - 10/2003
5	Thyroidectomy 01/2023 - 07/2002
3	Lasers (Laser) 09/2011 - 08/2006
2	Bariatric Surgery 05/2024 - 01/2019
2	Gastrectomy 05/2024 - 01/2019
2	Duration of Therapy 01/2019 - 10/2008
2	Kidney Transplantation 11/2012 - 02/2008
2	Light Coagulation 09/2011 - 08/2006
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 05/2024